TI
NAGE

Tidal Investments’s Niagen Bioscience NAGE Stock Holding History

Tidal Investments’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Buy
+123,506
New +$501K ﹤0.01% 2191
2025
Q3 		– Sell
-10,145
Closed -$146K – 2217
2025
Q2 		$146K Buy
+10,145
New +$100K ﹤0.01% 1792

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tidal Investments's NAGE Position: Q2 2026 in Review

Tidal Investments opened a new position in Niagen Bioscience (NAGE) in Q2 2026: 123,506 shares worth $394K. The stake represents ﹤0.01% of the portfolio and ranks #2191 among its holdings. This is a return to the name: Tidal Investments previously reported a position in NAGE as recently as Q2 2025.

Tidal Investments first reported a position in NAGE in Q2 2025 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Tidal Investments held 123,506 shares of Niagen Bioscience worth $394K as of Q2 2026.
  • Niagen Bioscience was a new Tidal Investments position in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2191 holding.
  • Tidal Investments first reported a position in Niagen Bioscience in Q2 2025 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.